These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 17378166)
41. Underlying medical conditions. Lombaard H; Pattinson RC Best Pract Res Clin Obstet Gynaecol; 2008 Oct; 22(5):847-64. PubMed ID: 18675594 [TBL] [Abstract][Full Text] [Related]
42. B-cell depletion for autoimmune thrombocytopenia and autoimmune hemolytic anemia in pediatric systemic lupus erythematosus. Kumar S; Benseler SM; Kirby-Allen M; Silverman ED Pediatrics; 2009 Jan; 123(1):e159-63. PubMed ID: 19074962 [TBL] [Abstract][Full Text] [Related]
43. Use of rituximab in patients with systemic lupus erythematosus: an update. García-Carrasco M; Jiménez-Hernández M; Escárcega RO; Mendoza-Pinto C; Galarza-Maldonado C; Sandoval-Cruz M; Zamudio-Huerta L; López-Colombo A; Cervera R Autoimmun Rev; 2009 Feb; 8(4):343-8. PubMed ID: 19036350 [TBL] [Abstract][Full Text] [Related]
44. Characteristics and outcome of connective tissue diseases in patients with sickle-cell disease: report of 30 cases. Michel M; Habibi A; Godeau B; Bachir D; Lahary A; Galacteros F; Fifi-Mah A; Arfi S Semin Arthritis Rheum; 2008 Dec; 38(3):228-40. PubMed ID: 18177923 [TBL] [Abstract][Full Text] [Related]
46. Cardiovascular risk assessment and treatment in systemic lupus erythematosus. Elliott JR; Manzi S Best Pract Res Clin Rheumatol; 2009 Aug; 23(4):481-94. PubMed ID: 19591779 [TBL] [Abstract][Full Text] [Related]
47. [Lupus nephritis as a factor of atherosclerosis risk in patients with systemic lupus erythematosus]. Serikova SIu; Kozlovskaia NL; Shilov EM Ter Arkh; 2008; 80(6):52-8. PubMed ID: 18655477 [TBL] [Abstract][Full Text] [Related]
48. Glatiramer acetate treatment does not modify the clinical course of (NZB x BXSB)F1 lupus murine model. Borel P; Benkhoucha M; Weber MS; Zamvil SS; Santiago-Raber ML; Lalive PH Int Immunol; 2008 Oct; 20(10):1313-9. PubMed ID: 18687587 [TBL] [Abstract][Full Text] [Related]
49. Climatic influence on the prevalence of noncutaneous disease flare in systemic lupus erythematosus in Hong Kong. Szeto CC; Mok HY; Chow KM; Lee TC; Leung JY; Li EK; Tsui TK; Yu S; Tam LS J Rheumatol; 2008 Jun; 35(6):1031-7. PubMed ID: 18398942 [TBL] [Abstract][Full Text] [Related]
50. Pregnancy and disease outcome in patients with systemic lupus erythematosus (SLE): a study at Srinagarind Hospital. Foocharoen C; Nanagara R; Salang L; Suwannaroj S; Mahakkanukrauh A J Med Assoc Thai; 2009 Feb; 92(2):167-74. PubMed ID: 19253790 [TBL] [Abstract][Full Text] [Related]
51. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases. Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207 [TBL] [Abstract][Full Text] [Related]
54. Stress and coping strategies in systemic lupus erythematosus: a review. Bricou O; Taïeb O; Baubet T; Gal B; Guillevin L; Moro MR Neuroimmunomodulation; 2006; 13(5-6):283-93. PubMed ID: 17709950 [TBL] [Abstract][Full Text] [Related]
55. [Acute systemic lupus erythematosus, developed after autoimmune crises, acute renal insufficiency and Werlhof's syndrome]. Beliaevskiĭ AI Vopr Revm; 1974; (3):61-4. PubMed ID: 4473863 [No Abstract] [Full Text] [Related]
56. General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus. Tomietto P; Annese V; D'agostini S; Venturini P; La Torre G; De Vita S; Ferraccioli GF Arthritis Rheum; 2007 Dec; 57(8):1461-72. PubMed ID: 18050188 [TBL] [Abstract][Full Text] [Related]